Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Other Working Capital Changes (2016 - 2025)

Alaunos Therapeutics (TCRT) has disclosed Other Working Capital Changes for 15 consecutive years, with -$166000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Working Capital Changes rose 51.74% year-over-year to -$166000.0, compared with a TTM value of -$356000.0 through Sep 2025, down 159.73%, and an annual FY2024 reading of -$539000.0, down 138.53% over the prior year.
  • Other Working Capital Changes was -$166000.0 for Q3 2025 at Alaunos Therapeutics, down from -$122000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $3.2 million in Q2 2021 and bottomed at -$9.2 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is -$519111.1, with a median of -$135500.0 recorded in 2022.
  • Peak annual rise in Other Working Capital Changes hit 1423.81% in 2024, while the deepest fall reached 526.53% in 2024.
  • Year by year, Other Working Capital Changes stood at -$9.2 million in 2021, then skyrocketed by 90.26% to -$895000.0 in 2022, then skyrocketed by 203.58% to $927000.0 in 2023, then crashed by 122.44% to -$208000.0 in 2024, then increased by 20.19% to -$166000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for TCRT at -$166000.0 in Q3 2025, -$122000.0 in Q2 2025, and $140000.0 in Q1 2025.